Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)

Human Molecular Genetics

Volumn 8, Issue 13, 1999, Pages 2407-2413

  Brandau, Oliver ^a   Schuster, Volker ^b   Weiss, Michael ^c   Hellebrand, Heide ^a   Fink, Franz M ^d   Kreczy, Alfons ^d   Friedrich, Wilhelm ^e   Strahm, Brigitte ^f   Niemeyer, Charlotte ^f   Belohradsky, Bernd H ^c   Meindl, Alfons ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF ULM   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DYSGAMMAGLOBULINEMIA; EPSTEIN BARR VIRUS; EXON; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MOLECULAR CLONING; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

HUMAN HERPESVIRUS 4;

EID: 0032756539     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.13.2407     Document Type: Article

References (22)

1. Purtilo, D.T., Cassel, C.K., Yang, J.P. and Harper, R. (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet, i, 935-940.
2. Seemayer, T.A., Gross, T.G., Egeler, R.M., Pirruccello, S.J., Davis, J.R., Kelly, C.M., Okano, M., Lanyi, A. and Sumegi, J. (1995) X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res., 38, 471-478.
3. Schuster, V. and Kreth, H.W. (1999) X-linked lymphoproliferative disease. In Ochs, H.D., Smith, C.I.E. and Puck, J. (eds), Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. Oxford University Press, New York, NY, Ch. 19, p. 222-232.
4. Gross, T.G., Patton, D.F., Davis, J.R., Sumegi, J., Pirruccello, S.J., Kelly, C.M. and Seemayer, T.A. (1994) X-linked lymphoproliferative disease (XLP) manifested without apparent EBV infection (abstract). Paper presented at Cold Spring Harbor Meeting on Cancer Cells: Epstein-Barr Virus and Associated Diseases, Cold Spring Harbor, NY.
5. Grierson, H.L., Skare, J., Hawk, J., Pauza, M. and Purtilo, D.T. (1991) Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am. J. Med. Genet., 40, 294-297.
6. Harrington, D.S., Weisenburger, D.D. and Purtilo, D.T. (1987) Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer, 59, 1419-1429.
7. Coffey, A.J., Brooksbank, R.A., Brandau, O., Oohashi, T., Howell, G.R., Bye, J.M., Cahn, A.P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C.J., Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B., Meindl, A. and Bentley, D.R. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet., 20, 129-135.
8. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., de Vries, J.E., Aversa, G. and Terhorst, C. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature, 395, 462-469.
9. Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M.. Valentine, M.B., Look, A.T., Gerald, W., Housman, D.E. and Haber, D.A. (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA, 95, 13765-13770.
10. Cocks, B.G., Chang, C.C., Carballido, J.M., Yssel, H., de Vries, J.E. and Aversa, G. (1995) A novel receptor involved in T-cell activation. Nature, 376, 260-263.
11. Tangye, S.G., Lazetic, S., Woollatt, E., Sutherland, G.R., Lanier, L.L. and Phillips, J.H. (1999) Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol., 162, 6981-6985.
12. Mathew, P.A., Garni-Wagner, B.A., Land, K., Takashima, A., Stoneman, E., Bennett, M. and Kumar, V. (1993) Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol., 151, 5328-5337.
13. Aversa, G., Caiballido, J., Punnonen, J., Chang, C.C., Hauser, T., Cocks, B.G. and de Vries, J.E. (1997) SLAM and its role in T cell activation and Th cell responses. Immunol. Cell Biol., 75, 202-205.
14. Punnonen, J., Cocks, B.G., Carballido, J.M., Bennett, B., Peterson, D., Aversa, G. and de Vries, J.E. (1997) Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med., 185, 993-1004.
15. Mikhalap, S.V., Shlapatska, L.M., Berdova, A.G., Law, C.L., Clark, E.A. and Sidorenko, S.P. (1999) CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J. Immunol., 162, 5719-5727.
16. Stein-Gerlach, M., Wallasch, C. and Ullrich, A. (1998) SHP-2, SH2-containing protein tyrosine phosphalase-2. Int. J. Biochem. Cell. Biol., 30, 559-566.
17. Sudol, M. (1998) From Src homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene, 17, 1469-1474.
18. Sullivan, J.L. and Woda, B.A. (1989) X-linked lymphoproliferative syndrome. Immunodefic. Rev., 1, 325-347.
19. Schuster, V., Kreß, W., Friedrich, W., Grimm, T. and Kreth, H.W. (1993) X-linked lymphoproliferative disease: detection of a paternally inherited mutation in a German family using haplotype analysis. Am. J. Dis. Child., 147, 1303-1305.
20. Schuster, V., Grimm, T., Kreß, W., Seidenspinner, S., Belohradsky, B.H., Müller, P. and Kreth, H.W. (1995) Die X-chromosomal-rezessive lymphoproliferative Erkrankung (XLP) Molekulargenetische Untersuchungen. Klin. Pädiatr., 207, 271-276.
21. Schuster, V., Seidenspinner, S., Grimm, T., Kreß, W., Zielen, S., Bock, M. and Kreth, H.W. (1994) Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease. Eur. J. Pediatr., 153, 432-437.
22. Korbjuhn, P., Anagnostopoulos, I., Hummel, M., Tiemann, M., Dallenbach, F., Pawaresch, M.R. and Stein, H. (1993) Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus negative European peripheral pleomorphic T-cell lymphomas. Blood, 82, 217-223.